Literature DB >> 30150904

Factors Associated with Sexual Dysfunction in Individuals with Multiple Sclerosis: Implications for Assessment and Treatment.

Samantha Domingo, Tyler Kinzy, Nicolas Thompson, Shauna Gales, Lael Stone, Amy Sullivan.   

Abstract

BACKGROUND: Sexual dysfunction is a common symptom of multiple sclerosis (MS) that often goes unreported by both the patient and the clinician. Sexual dysfunction can affect a person's mood, relationships, daily functioning, and quality of life. Gaining a better understanding of the prevalence and nature of sexual dysfunction in individuals with MS would not only help identify patients with this problem but also determine contributing factors, which can inform treatment alternatives available to the patient.
METHODS: Patients with a diagnosis of MS (n = 162) completed the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 during their neurology appointments at the Mellen Center for Multiple Sclerosis at Cleveland Clinic. These data were merged with Knowledge Program data collected as part of standard practice and included measures of mood, disability, and quality of life.
RESULTS: Sexual dysfunction was present in 64.2% of the clinic sample. Patients with sexual dysfunction had significantly worse average MS-related disability and depressive symptom scores.
CONCLUSIONS: Sexual dysfunction is highly prevalent in the MS clinic sample. Assessment and treatment of depression may serve as a starting point for intervention in patients with MS who experience sexual dysfunction. Identifying individuals who are at risk for sexual dysfunction concerns may help with clinician and patient burden in terms of routine assessment of this symptom.

Entities:  

Year:  2018        PMID: 30150904      PMCID: PMC6107343          DOI: 10.7224/1537-2073.2017-059

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  11 in total

1.  Sexual Dysfunction and Depression in Individuals with Multiple Sclerosis: Is there a Link?

Authors:  Rocco Salvatore Calabrò; Margherita Russo
Journal:  Innov Clin Neurosci       Date:  2015 May-Jun

2.  The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.

Authors:  Laura C Schairer; Frederick W Foley; Vance Zemon; Tuula Tyry; Denise Campagnolo; Ruth Ann Marrie; Elizabeth S Gromisch; David Schairer
Journal:  Mult Scler       Date:  2013-09-02       Impact factor: 6.312

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

Review 4.  Improving quality of life in multiple sclerosis: an unmet need.

Authors:  Howard L Zwibel; Jennifer Smrtka
Journal:  Am J Manag Care       Date:  2011-05       Impact factor: 2.229

5.  The Knowledge Program: an innovative, comprehensive electronic data capture system and warehouse.

Authors:  Irene Katzan; Micheal Speck; Chris Dopler; John Urchek; Kay Bielawski; Cheryl Dunphy; Lara Jehi; Charles Bae; Alandra Parchman
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

Review 6.  Sexual dysfunction in male patients with multiple sclerosis: a need for counseling!

Authors:  Rocco Salvatore Calabrò; Rosaria De Luca; Valeria Conti-Nibali; Simone Reitano; Antonino Leo; Placido Bramanti
Journal:  Int J Neurosci       Date:  2013-12-10       Impact factor: 2.292

7.  Effects of multiple sclerosis on female sexuality: a controlled study.

Authors:  Haluk Gumus; Zehra Akpinar; Halim Yilmaz
Journal:  J Sex Med       Date:  2013-12-02       Impact factor: 3.802

8.  Correlates of sexual function in male and female patients with multiple sclerosis.

Authors:  Michal Lew-Starowicz; Rafal Rola
Journal:  J Sex Med       Date:  2014-06-26       Impact factor: 3.802

9.  Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9).

Authors:  Bernd Löwe; Kurt Kroenke; Wolfgang Herzog; Kerstin Gräfe
Journal:  J Affect Disord       Date:  2004-07       Impact factor: 4.839

10.  Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group.

Authors:  C E Schwartz; T Vollmer; H Lee
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910

View more
  6 in total

Review 1.  The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis.

Authors:  Nader Salari; Razie Hasheminezhad; Amir Abdolmaleki; Aliakbar Kiaei; Nazanin Razazian; Shamarina Shohaimi; Masoud Mohammadi
Journal:  Neurol Sci       Date:  2022-09-17       Impact factor: 3.830

2.  Barriers to quality of life in patients with multiple sclerosis: a qualitative study.

Authors:  Zahra Hosseini; Atefeh Homayuni; Masoud Etemadifar
Journal:  BMC Neurol       Date:  2022-05-13       Impact factor: 2.903

3.  Psychobehavioral Treatment Options for Sexual Dysfunction in Multiple Sclerosis: A Systematic Review.

Authors:  Jana Pöttgen; Wim van de Vis; An van Nunen; Anita Rose; Jannie Engelbrecht; Michelle Pirard; Stephanie Lau; Christoph Heesen; Sascha Köpke
Journal:  Int J MS Care       Date:  2020-12-28

Review 4.  Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms-A Narrative Review.

Authors:  Lynsey Lakin; Bryan E Davis; Cherie C Binns; Keisha M Currie; Mary R Rensel
Journal:  Neurol Ther       Date:  2021-04-20

5.  Factors associated with intimacy and sexuality among young women with multiple sclerosis.

Authors:  Khadijeh Mohammadi; Parvin Rahnama; Zahra Rafei; Seyedeh Mitra Ebrahimi-Aveh; Ali Montazeri
Journal:  Reprod Health       Date:  2020-07-10       Impact factor: 3.223

6.  Association between Psychopathological Dimensions and Sexual Functioning/Sexual Arousal in Young Adults.

Authors:  Franklin Soler; Reina Granados; Ana I Arcos-Romero; Cristóbal Calvillo; Ana Álvarez-Muelas; María Del Mar Sánchez-Fuentes; Nieves Moyano; Juan Carlos Sierra
Journal:  Int J Environ Res Public Health       Date:  2021-03-30       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.